https://www.infectiousdiseaseadvisor.com/home/topics/hiv-aids/inflammatory-biomarkers-hiv-antiretroviral-therapy-2-drug-regimen/
0
0
9/8/22 at 2:52pm
Organization
Infectiousdiseaseadvisor.com
Author
melissaalvarez
42 words
0
Comments
Researchers evaluated inflammatory biomarkers among patients with HIV who switched from a 3-drug antiretroviral therapy regimen to a 2-drug regimen of dolutegravir plus lamivudine.
You are the first to view
Create an account
or login to join the discussion